319
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Scandinavian journal of gastroenterology – the editors-in-chief

Pages 630-635 | Received 09 Mar 2015, Accepted 10 Mar 2015, Published online: 24 Mar 2015

References

  • KRNorum, EGjone. Familial serum-cholesterol esterification failure. A new inborn error of metabolism. Biochim Biophys Acta 1967;144:698–700.
  • CChen, KApplegate, WCKing, JAGlomset, KRNorum, EGjone. A study of the small spherical high density lipoproteins of patients afflicted with familial lecithin: cholesterol acyltransferase deficiency. J Lipid Res 1984;25:269–82.
  • PTeisberg, EGjone, BOlaisen. Genetics of LCAT (lecithin: cholesterol acyltransferase) deficiency. Ann Hum Genet 1975;38:327–31.
  • EGjone, PBjornstad. [Vitamin B 12 absorption in steatorrhea]. Tidsskr Nor Laegeforen 1964;84:1486–8.
  • EGjone, OMOrning, JMyren. Crohn’s disease in Norway 1956-63. Gut;1966;7:372–4.
  • EGjone, AOyri. Protein-losing enteropathy in dermatitis herpetiformis. Scand J Gastroenterol 1970;5:13–15.
  • EGjone, JMyren. [Ulcerative colitis in Norway]. Nord Med 1964;71:143–5.
  • AFlatmark, BFretheim, EGjone. Early colectomy in severe ulcerative colitis. Scand J Gastroenterol 1975;10:427–31.
  • ONGruner, RNaas, AFlatmark, BFretheim, EGjone. Ileostomy in ulcerative colitis. Results in 149 patients. Scand J Gastroenterol 1976;11:777–84.
  • OPGruner, AFlatmark, RNaas, BFretheim, EGjone. Ileorectal anastomosis in ulcerative colitis. Results in 57 patients. Scand J Gastroenterol 1975;10:641–6.
  • MHVatn, OFausa, EGjone. Diagnostic value of gastrointestinal endoscopy in patients with uncharacteristic abdominal disorders. Scand J Gastroenterol 1985;20:636–40.
  • EAadland, ESchrumpf, OFausa, KElgjo, AHeilo, TAakhus, et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987;22:655–64.
  • LEHanssen, PTorjesen. Radioimmunossay of secretin in human plasma. Scand J Gastroenterol 1977;12:481–8.
  • LEHanssen, KFHanssen, JMyren. Inhibition of secretin release and pancreatic bicarbonate secretion by somatostatin infusion in man. Scand J Gastroenterol 1977;12:391–4.
  • MOsnes, LEHanssen, OFlaten, JMyren. Exocrine pancreatic secretion and immunoreactive secretin (IRS) release after intraduodenal instillation of bile in man. Gut 1978;19:180–4.
  • ETheodorsson, SLarsen, PRiis, LEHanssen. Statistical guidelines for contributors to Scandinavian Journal of Gastroenterology. Scand J Gastroenterol 1990;25:545–7.
  • LEHanssen, ESchrumpf, ANKolbenstvedt, JTausjø, LODolva. Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization. Scand J Gastroenterol 1989;24:787–95.
  • FKolmannskog, ANKolbenstvedt, ESchrumpf, LEHanssen. Side effects and complications after hepatic artery embolization in the carcinoid syndrome. Scand J Gastroenterol 1991;26:557–62.
  • OSoreide, TBerstad, ABakka, ESchrumpf, LEHanssen, VEngh, et al. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery 1992;111:48–54.
  • MBJacobsen, JBratlie, JBReitan, JHellesnes, LEHanssen. Influence of interferon and radiation on serotonin content in primary carcinoid cell cultures. Acta Oncol 1993;32:239–43.
  • MBJacobsen, LEHanssen. Clinical effects of octreotide compared to placebo in patients with gastrointestinal neuroendocrine tumours. Report on a double-blind, randomized trial. J Intern Med 1995;237:269–75.
  • JEReseland, FLarsen, JSolheim, JAEriksen, LEHanssen, HPrydz. A novel human chymotrypsin-like digestive enzyme. J Biol Chem 1997;272:8099–104.
  • ESchrumpf, HPetersen, ABerstad, JMyren, BRosenlund. The effect of secretin on plasma gastrin in the Zollinger-Ellison syndrome. Scand J Gastroenterol 1973;8:145–50.
  • ESchrumpf, TSand. Radioimmunoassay of gastrin with activated charcoal. Scand J Gastroenterol 1972;7:683–7.
  • ESchrumpf, LSSemb, HVold. Metabolic clearance and disappearance rates of synthetic human gastrin in man. Scand J Gastroenterol 1973;8:731–4.
  • ESchrumpf, JStadaas. Effect of gastric distention on motility and plasma gastrin concentration before and after secretin administration. Scand J Gastroenterol 1974;9:119–22.
  • ESchrumpf, MHVatn, KFHanssen, SSemb, JMyren. Somatostatin inhibits insulin-stimulated gastrin release and gastric secretion of acid, pepsin, and intrinsic factor (IF) in duodenal ulcer patients. Scand J Gastroenterol 1976;11:517–20.
  • KBjoro, ESchrumpf, ABergan, AFlatmark, OMathisen, GSødal, et al. [Liver transplantation in Norway. Results after 10 years and 114 transplantations]. Tidsskr Nor Laegeforen 1996;116:19–24.
  • HBell, ESchrumpf, MKFagerhol. Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease. Scand J Gastroenterol 1990;25:788–92.
  • ARydning, ESchrumpf, MAbdelnoor, KElgjo, EJenssen. Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 1990;25:119–26.
  • ESchrumpf. Association of primary sclerosing cholangitis and celiac disease: fact or fancy? Hepatology 1989;10:1020–1.
  • ESchrumpf, KElgjo, OFausa, GHaukenes, DKvale, HRollag. The significance of anti-hepatitis C virus antibodies measured in chronic liver disease. Scand J Gastroenterol 1990;25:1169–74.
  • ESchrumpf, OFausa, KElgjo, FKolmannskog. Hepatobiliary complications of inflammatory bowel disease. Semin Liver Dis 1988;8:201–9.
  • ESchrumpf, OFausa, OFørre, JHDobloug, SRitland, EThorsby. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 1982;17:187–91.
  • ESchrumpf, EGjone. Hepatobiliary disease in ulcerative colitis. Scand J Gastroenterol 1982;17:961–4.
  • KBjoro, BBrandsaeter, AFoss, ESchrumpf. Liver transplantation in primary sclerosing cholangitis. Semin Liver Dis 2006;26:69–79.
  • KMBoberg, PJebsen, OPClausen, LAabakken, IBrekke, ESchrumpf. Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation. J Hepatol 2003;39:453.
  • KMBoberg, PJebsen, OPClausen, AFoss, LAabakken, ESchrumpf. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol 2006;45:568–74.
  • ESchrumpf, MAbdelnoor, OFausa, KElgjo, EJenssen, FKolmannskog. Risk factors in primary sclerosing cholangitis. J Hepatol 1994;21:1061–6.
  • ESchrumpf, KMBoberg. Epidemiology of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2001;15:553–62.
  • ESchrumpf, KMBoberg. Hepatic and extrahepatic malignancies and primary sclerosing cholangitis. Gut 2003;52:165.
  • ESchrumpf, OFausa, EAadland. Primary sclerosing cholangitis. Scand J Gastroenterol 1987;22:641–3.
  • ESchrumpf, OFausa, FKolmannskog, KElgjo, SRitland, EGjone. Sclerosing cholangitis in ulcerative colitis. A follow-up study. Scand J Gastroenterol 1982;17:33–9.
  • KMBoberg, ASpurkland, GRocca, TEgeland, SSaarinen, SMitchell, et al. The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. Scand J Gastroenterol 2001;36:886–90.
  • THKarlsen, AFranke, EMelum, AKaser, JRHov, TBalschun, et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010;138:1102–11.
  • THKarlsen, ESchrumpf, KBoberg. Genetic epidemiology of primary sclerosing cholangitis. World J Gastroenterol 2007;13:5421–31.
  • EMelum, AFranke, CSchramm, TJWeismüller, DNGotthardt, FAOffner, et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet 2011;43:17–19.
  • ABerstad, HPetersen. A comparison between the effects of secretin and histamine on the gastric secretion of pepsin in man. Scand J Gastroenterol 1969;4:511–15.
  • ABerstad. Stimulation of gastric secretion of pepsin by secretin in man. Scand J Gastroenterol 1969;4:617–22.
  • MRoland, ABerstad, ILiavag. Decrease in gastric secretion during the first three months after proximal gastric vagotomy in duodenal ulcer patients. Scand J Gastroenterol 1975;10:363–7.
  • EAadland, ABerstad, LSSemb. Effect of cimetidine on pentagastrin-stimulated gastric secretion in healthy man. Scand J Gastroenterol 1977;12:501–6.
  • ABerstad, KKett, EAadland, ECarlsen, KFrislid, KSaxhaug, et al. Treatment of duodenal ulcer with ranitidine, a new histamine H2-receptor antagonist. Scand J Gastroenterol 1980;15:637–9.
  • ABerstad, ARydning, EAadland, BKolstad, KFrislid, JAaseth. Controlled clinical trial of duodenal ulcer healing with antacid tablets. Scand J Gastroenterol 1982;17:953–9.
  • ABerstad, CJBang, ITalstad. A new model to assess the haemorrhagic potential of various heparin preparations. Acta Chir Scand Suppl 1990;556:62–7.
  • CJBang, ABerstad, ITalstad. Gastric mucosal bleeding after unfractionated and low molecular weight heparin in rats. Scand J Gastroenterol 1990;25:379–82.
  • IWilhelmsen, TTangen Haug, PSipponen, ABerstad. Helicobacter pylori in functional dyspepsia and normal controls. Scand J Gastroenterol 1994;29:522–7.
  • TTHaug, IWilhelmsen, ABerstad, HUrsin. Life events and stress in patients with functional dyspepsia compared with patients with duodenal ulcer and healthy controls. Scand J Gastroenterol 1995;30:524–30.
  • OHGilja, THausken, Sdegaard, ABerstad. Gastric emptying measured by ultrasonography. World J Gastroenterol 1999;5:93–4.
  • GArslan, SØdegaard, SElsayed, EFlorvaag, ABerstad. Food allergy and intolerance: response to intestinal provocation monitored by endosonography. Eur J Ultrasound 2002;15:29–36.
  • OHGilja, AHeimdal, THausken, HGregersen, KMatre, ABerstad, et al. Strain during gastric contractions can be measured using Doppler ultrasonography. Ultrasound Med Biol 2002;28:1457–65.
  • ABerstad, MHMorken, GArslan Lied, RLind, ASHjartholm, JValeur. Fecal fat excretion in irritable bowel syndrome. Scand J Gastroenterol 2012;47:1120–1.
  • ABerstad, RUndseth, RLind, JValeur. Functional bowel symptoms, fibromyalgia and fatigue: a food-induced triad? Scand J Gastroenterol 2012;47:914–19.
  • KBjoro, HBell, KBHellum, KSkaug, NRaknerud, PSandvei, et al. Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study. Scand J Gastroenterol 2002;37:226–32.
  • ODalgard, KBjøro, HRing-Larsen, EBjornsson, MHolberg-Petersen, ESkovlund, et al. Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response. Hepatology 2008;47:35–42.
  • KBjoro, SSFrøland, ZYun, HHSamdal, THaaland. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994;331:1607–11.
  • KBjoro, THaaland, KSkaug, SSFrøland. The spectrum of hepatobiliary disease in primary hypogammaglobulinaemia. J Intern Med 1999;245:517–24.
  • KBjoro, BGEriczon, PKirkegaard, KHöckerstedt, GSöderdahl, MOlausson, et al. Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation. Transplantation 2003;75:347–53.
  • BBrandsaeter, HIsoniemi, UBroomé, MOlausson, LBäckman, BHansen, et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 2004;40:815–22.
  • PGBurhol, ILygren, HLWaldum. Radioimmunoassay of vasoactive intestinal polypeptide in plasma. Scand J Gastroenterol 1978;13:807–13.
  • HLWaldum, PGBurhol, BKStraume. Serum group I pepsinogens during prolonged infusion of pentagastrin and secretin in man. Scand J Gastroenterol 1979;14:761–8.
  • HLWaldum. Radioimmunoassay of pepsin in gastric juice. Prog Clin Biol Res 1985;173:75–8.
  • AKSandvik, HLWaldum, PMKleveland, BSchulze Søgnen. Gastrin produces an immediate and dose-dependent histamine release preceding acid secretion in the totally isolated, vascularly perfused rat stomach. Scand J Gastroenterol 1987;22:803–8.
  • AKSandvik, MJLewin, HLWaldum. Histamine release in the isolated vascularly perfused stomach of the rat: regulation by autoreceptors. Br J Pharmacol 1989;96:557–62.
  • AKSandvik, JJHolst, WLWaldum. The effect of gastrin-releasing peptide on acid secretion and the release of gastrin, somatostatin, and histamine in the totally isolated, vascularly perfused rat stomach. Scand J Gastroenterol 1989;24:9–15.
  • HLWaldum, AKSandvik, EBrenna, HPetersen. Gastrin-histamine sequence in the regulation of gastric acid secretion. Gut 1991;32:698–701.
  • HLWaldum, OAHaugen, CIsaksen, RMecsei, AKSandvik. Enterochromaffin-like tumour cells in the diffuse but not the intestinal type of gastric carcinomas. Scand J Gastroenterol Suppl 1991;180:165–9.
  • EBrenna, RHåkanson, FSundler, AKSandvik, HLWaldum. The effect of omeprazole-induced hypergastrinemia on the oxyntic mucosa of mastomys. Scand J Gastroenterol 1991;26:667–72.
  • TCMartinsen, SKawase, RHåkanson, SHTorp, RFossmark, GQvigstad, et al. Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist. Carcinogenesis 2003;24:1887–96.
  • RFossmark, TCMartinsen, GQvigstad, MØBendheim, GKopstad, KKashima, et al. Ultrastructure and chromogranin A immunogold labelling of ECL cell carcinoids. APMIS 2005;113:506–12.
  • CSJianu, RFossmark, TViset, GQvigstad, OSørdal, RMårvik, et al. Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment Pharmacol Ther 2012;36:644–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.